Molecure S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
For the nine months, sales was PLN 1.23 million compared to PLN 1.47 million a year ago. Net loss was PLN 11.51 million compared to PLN 9.36 million a year ago. Basic loss per share from continuing operations was PLN 0.68 compared to PLN 0.67 a year ago. Diluted loss per share from continuing operations was PLN 0.68 compared to PLN 0.67 a year ago.